STEP 5 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Archive — January 2024
Page 5 of 5 of this archive, newest first.
A supplier suspends shipping to Norway after 23 consecutive customs detentions
The route did not close because of a rule about peptides.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Background rates, and why they matter for attribution
The features that should prompt urgent assessment, stated once and plainly.
The tolerability data everybody quotes and nobody reads
Almost every figure in circulation about tolerability comes from six publications. This is what they say.
A tested vial is evidence about a vial
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
VendorInvestigate result on a Hong Kong dulaglutide lot lands 2.0 points above the supplier’s stated figure
A reminder that a purity figure is the output of a method, and that methods differ.
What changed at WXT in January, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new Nigeria guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.